Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial - Quiz - MDSpire

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

  • By

  • Inês Nobre

  • Marlene N. Silva

  • Sofia Franco

  • Bruno Rodrigues

  • Pedro F. Silva

  • Pedro J. Teixeira

  • Eliana V. Carraça

  • May 14, 2026

  • 0 min

Share

Original Source(s)

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

  • by Inês Nobre, Marlene N. Silva, Sofia Franco, Bruno Rodrigues, Pedro F. Silva, Pedro J. Teixeira, Eliana V. Carraça

  • May 14, 2026

Related Content

A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review

Case Report: Pembrolizumab unmasks a capillary leak syndrome with chylothorax in early TNBC

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology